Iterum Therapeutics plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CAPTRUST FINANCIAL ADVISORS | 11/19/2025 | 111.60 K | $74.77 K | 870.43% | 0.28% |
| GEN-WEALTH PARTNERS INC | 11/14/2025 | 82.05 K | $54.97 K | 100.00% | 0.21% |
| BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC | 10/22/2025 | 66 | $44 | 0.00% | 0.00% |
| CYPRESS CAPITAL MANAGEMENT LLC (WY) | 11/03/2025 | 66 | $44 | 100.00% | 0.00% |
| CREATIVE FINANCIAL DESIGNS INC /ADV | 11/12/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Iterum Therapeutics plc institutional Ownership - FAQ's
During the previous two years, 14 institutional investors and hedge funds held shares of Iterum Therapeutics plc. The most heavily invested institutionals were:
CAPTRUST FINANCIAL ADVISORS: 111,600
Gen-Wealth Partners Inc: 82,047
BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC: 66
Cypress Capital Management LLC (WY): 66
CREATIVE FINANCIAL DESIGNS INC /ADV: 0
American Portfolios Advisors: 0
0.49% of Iterum Therapeutics plc stock is owned by institutional investors.
Institutional investors have bought a total of 810.71 K shares in the last 24 months. This purchase volume represents approximately $543.74 K in transactions.